Preventable Blood Clots Responsible for Many Patient Deaths: New Study
Preventable blood clots that travel to the lungs could be responsible for 5% to 10% of hospital deaths, according to a study recently published in the American Journal of Hematology, and supported by funding from Sanofi-Aventis, a manufacturer of pharmaceuticals which include blood thinners. The researchers say some patients are genetically predisposed to the clots, and that although one in three is at risk of developing them in the hospital, very few receive preventive treatment. Further, the research suggests that anyone over 18 who spends more than two days in the hospital following major surgery -- particularly hip or knee surgery -- faces high risk of developing a Deep Vein Thrombosis (DVT). Though such clots will not necessarily become fatal, such potential does exist. Authors of the study recommend vigilance in recognizing the warning signs of DVT, and urge doctors to prescribe blood thinners for inactive, post-operative patients.
According to the National Heart Lung and Blood Institute, the signs and symptoms of DVT may include:
- "Swollen area of the leg.
- Pain or tenderness in the leg. The pain is usually in one leg and may be felt only when standing or walking.
- Increased warmth in the area of the leg that is swollen or in pain.
- Red or discolored skin."
- "Chest pain when you take a deep breath
- Shortness of breath"
Previously on the D.C. Metro Area Medical Malpractice Law Blog, we have posted articles concerning: